Evommune (EVMN) Other Non Operating Income (2024 - 2026)

Evommune (EVMN) has 3 years of Other Non Operating Income data on file, last reported at $2.3 million in Q1 2026.

• On a quarterly basis, Other Non Operating Income rose 380.0% year-over-year to $2.3 million in Q1 2026; TTM through Mar 2026 was $13.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $12.2 million, up 280.69% from the prior year.
• Other Non Operating Income for Q1 2026 stood at $2.3 million, down from $9.4 million in the prior quarter.
• Over the last five years, Other Non Operating Income for EVMN reached as high as $9.4 million in Q4 2025 and fell as low as $475000.0 in Q1 2025.
• Historically, Other Non Operating Income has averaged $2.4 million across 3 years, with a median of $790500.0 in 2024.
• On a YoY basis, Other Non Operating Income climbed as much as 1195.33% in 2025 and fell as far as 41.93% in 2025.
• Year by year, Other Non Operating Income stood at $728000.0 in 2024, then jumped by 1195.33% to $9.4 million in 2025, then slumped by 75.82% to $2.3 million in 2026.
• Per Business Quant data, the three most recent Other Non Operating Income figures were $2.3 million in Q1 2026, $9.4 million in Q4 2025, and $853000.0 in Q3 2025.